Sodium Glycerophoshate 21.6%

For GB healthcare professionals only. This content contains promotional and brand information.
 
Scroll down for prescribing information for micronutrient parenteral nutrition (PN) products and further product information. Adverse event reporting details are available at the bottom of this webpage.

Organic phosphate concentrate for solution for infusion (1mmol PO4/ml) 
 
PN should be monitored, and doses adjusted according to individual patient response. Please refer to the Summary of Product Characteristics before prescribing.

Please note product image is for illustrative purposes only and labelling on actual product may appear differently.
 

Filename
Prescribing information parenteral nutrition micronutrients.pdf
Size
150 KB
Format
pdf
PN Micronutrient Prescribing Information

Details

Sodium Glycerophosphate 21.6%
 per ml per 20ml ampoule 
Phosphate1mmol20mmol
Sodium 2mmol40mmol

 

  • Supplied in a 20ml ampoule
  • Must not be given undiluted - see SmPC for compatibility details with other solutions
  • A wide range of compatibility and stability data is also available from the medical information department at: Medical.Information-UK@fresenius-kabi.com

​Indicated in adult patients as a supplement in intravenous nutrition to meet the requirements of phosphate.

Item descriptionUnit size Case qty Item code 
Sodium Glycerophosphate 21.6% 20ml10FYA1963

 

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk Adverse events should also be reported to Fresenius Kabi Limited.  Email: Pharmacovigilance.GB@fresenius-kabi.com

GB-SodGly-2400003 January 2026

By entering the Healthcare Professional Area you are confirming you are a GB Healthcare Professional. This area contains promotional information. If you are not a Healthcare Professional you will be directed to the Fresenius Kabi GB Corporate website.

GB-NP-2400163 October 2024

I am a Healthcare Professional I am not a Healthcare Professional